In Vivo MRI in Different Models of Experimental Epilepsy
Journal:
Current Drug Targets
Volume:
5
Page:
629-636
Author(s):
P. F. Fabene and A. Sbarbati
Clinical Pharmacotherapy for Obesity: Current Drugs and Those in Advanced Development
Journal:
Current Drug Targets
Volume:
5
Page:
637-646
Author(s):
Jason C.G. Halford
Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Journal:
Current Drug Metabolism
Volume:
5
Page:
415-442
Author(s):
Shufeng Zhou, Eli Chan, Lee Yong Lim, Urs A. Boelsterli, Shu Chuen Li, Jiancheng Wang, Qiang Zhang, Min Huang and Anlong Xu
Lipoproteins and Diabetic Microvascular Complications
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3395-3418
Author(s):
A. J. Jenkins, K. G. Rowley, T. J. Lyons, J. D. Best, M. A. Hill and R. L. Klein
Cellular and Physiological Effects of Arginine
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
823-832
Author(s):
Betty C. Tong and Adrian Barbul
Hemodynamic Regulation of Metallopeptidases within the Vasculature
Journal:
Protein & Peptide Letters
Volume:
11
Page:
433-442
Author(s):
Philip M. Cummins, Eoin J. Cotter and Paul A. Cahill
Non-Lipid Effects of Statins: Emerging New Indications
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
309-318
Author(s):
Aylin Yildirir and Haldun Muderrisoglu
Inhibition of the Tissue Factor Coagulation Pathway
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
319-327
Author(s):
Paolo Golino, Lavinia Forte and Salvatore De Rosa
23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
329-333
Author(s):
Michael Horn
Antioxidant Therapy in Diabetic Complications: What is New?
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
335-341
Author(s):
Roberto Da Ros, Roberta Assaloni and Antonio Ceriello